Tonix Pharmaceuticals Holding Corp.
TNXP
$13.46
$0.221.68%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 63.83% | 64.66% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 63.83% | 64.66% | |||
| Cost of Revenue | -22.60% | -58.22% | |||
| Gross Profit | 125.27% | 250.94% | |||
| SG&A Expenses | 38.82% | 58.63% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 47.64% | 20.01% | |||
| Operating Income | -46.02% | -16.86% | |||
| Income Before Tax | -46.55% | -13.22% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -46.55% | -13.22% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -46.55% | -13.22% | |||
| EBIT | -46.02% | -16.86% | |||
| EBITDA | -46.59% | -17.23% | |||
| EPS Basic | -10.83% | 7.03% | |||
| Normalized Basic EPS | -10.82% | 7.02% | |||
| EPS Diluted | -10.83% | 7.03% | |||
| Normalized Diluted EPS | -10.82% | 7.02% | |||
| Average Basic Shares Outstanding | 32.23% | 21.77% | |||
| Average Diluted Shares Outstanding | 32.23% | 21.77% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||